Detalhe da pesquisa
1.
A growth-factor-activated lysosomal K+ channel regulates Parkinson's pathology.
Nature
; 591(7850): 431-437, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33505021
2.
GPNMB Biomarker Levels in GBA1 Carriers with Lewy Body Disorders.
Mov Disord
; 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38610104
3.
Pathologic and cognitive correlates of plasma biomarkers in neurodegenerative disease.
Alzheimers Dement
; 2024 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38644682
4.
Alzheimer Disease Biomarkers: Moving from CSF to Plasma for Reliable Detection of Amyloid and tau Pathology.
Clin Chem
; 69(11): 1247-1259, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37725909
5.
Plasma MIA, CRP, and Albumin Predict Cognitive Decline in Parkinson's Disease.
Ann Neurol
; 92(2): 255-269, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35593028
6.
Elevated Plasma Phosphorylated Tau 181 in Amyotrophic Lateral Sclerosis.
Ann Neurol
; 92(5): 807-818, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35877814
7.
Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease.
Acta Neuropathol
; 143(1): 15-31, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34854996
8.
Author Correction: A growth-factor-activated lysosomal K+ channel regulates Parkinson's pathology.
Nature
; 592(7855): E10, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33790472
9.
Provider Experience with Teleneurology in an Academic Neurology Department.
Telemed J E Health
; 28(3): 374-383, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34077285
10.
Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease.
Mov Disord
; 36(12): 2945-2950, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34480363
11.
Temporal trends and yield of clinical diagnostic genetic testing in adult neurology.
Am J Med Genet A
; 185(10): 2922-2928, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34075706
12.
Transitioning to telegenetics in the COVID-19 era: Patient satisfaction with remote genetic counseling in adult neurology.
J Genet Couns
; 30(4): 974-983, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34265143
13.
Rare Gain-of-Function KCND3 Variant Associated with Cerebellar Ataxia, Parkinsonism, Cognitive Dysfunction, and Brain Iron Accumulation.
Int J Mol Sci
; 22(15)2021 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34361012
14.
TMEM106B Effect on cognition in Parkinson disease and frontotemporal dementia.
Ann Neurol
; 85(6): 801-811, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30973966
15.
ADNC-RS, a clinical-genetic risk score, predicts Alzheimer's pathology in autopsy-confirmed Parkinson's disease and Dementia with Lewy bodies.
Acta Neuropathol
; 140(4): 449-461, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32749525
16.
Concomitant Alzheimer Disease Pathology in Parkinson Disease Dementia.
Ann Neurol
; 93(5): 1045-1046, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36892304
17.
Early and Accurate Diagnosis of Parkinson Disease May Be Rooted in Seed Amplification Assays.
Clin Chem
; 69(11): 1209-1211, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37688494
18.
APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.
Mov Disord
; 33(2): 289-297, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29168904
19.
Provider Impressions of Inpatient Teleneurology Consultation.
Neurol Clin Pract
; 14(3): e200296, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38737514
20.
α-Synuclein Conformations in Plasma Distinguish Parkinson's Disease from Dementia with Lewy Bodies.
bioRxiv
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38765963